{"id":"W2296118977","doi":"10.3109/10428194.2015.1128540","title":"Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*","year":2016,"lang":"en","type":"article","venue":"Leukemia & lymphoma/Leukemia and lymphoma","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Lenalidomide; Medicine; Tolerability; Neutropenia; Internal medicine; Discontinuation; Refractory (planetary science); Chronic lymphocytic leukemia; Adverse effect; Gastroenterology; Oncology; Surgery; Leukemia; Chemotherapy; Multiple myeloma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00489546,0.001347826,0.002821659,0.0003793721,0.0005021053,0.001120092,0.0008462061,0.00160465,0.002400928],"category_scores_gemma":[0.003345771,0.0006158659,0.001924615,0.0004880664,0.001216288,0.001015468,0.000312423,0.002381665,0.0004877102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008769451,"about_ca_system_score_gemma":0.001122511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004958653,"about_ca_topic_score_gemma":0.001168917,"domain_scores_codex":[0.9978873,0.00145904,0.0001866088,0.0002156347,0.0001205371,0.0001308634],"domain_scores_gemma":[0.9974081,0.0009502445,0.0006831905,0.0002915402,0.0001576718,0.0005092277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9481549,0.01237216,0.002143977,0.0003468576,0.001043716,0.00002548748,0.00007492599,0.0003309726,0.006089524,0.00004329194,0.0003760896,0.02899802],"study_design_scores_gemma":[0.8292229,0.1648613,0.00339211,0.00002807184,0.0006181484,0.00003648018,0.00002049388,0.000326934,0.0008665605,0.00006716236,0.0005422918,0.00001765386],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895191,0.005121273,0.0007043332,0.0003613388,0.0001482896,0.002478734,0.0005848496,0.00007861988,0.001003592],"genre_scores_gemma":[0.990373,0.002044082,0.002077271,0.0008569582,0.0003028452,0.00278587,0.000850267,0.00003162947,0.0006780749],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00489546,"threshold_uncertainty_score":0.02588999,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01989551389267892,"score_gpt":0.3024081237141699,"score_spread":0.282512609821491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}